The Function of Circular RNAs in Myocardial Ischemia–Reperfusion Injury: Underlying Mechanisms and Therapeutic Advancement

Chen, Kai-Yuan; Liu, Zhou; Lu, Jun-Hou; Yang, Si-Yuan; Hu, Xuan-Yi; Liang, Gui-You

doi:10.1007/s10557-024-07557-1

Cited by 2 publications

(1 citation statement)

References 119 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the exploration of miRNA mimicry or inhibition as therapeutic strategies in clinical trials could open new avenues for treatment [ 1 , 3 ]. Additionally, a comprehensive review on the therapeutic targets and biomarkers of non-coding RNAs highlights the growing significance of these molecules in cardiovascular diseases and underscores the potential for developing novel RNA-based therapies [ 35 ].…”

Section: Discussionmentioning

confidence: 99%

MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension—A Systematic Review

Kondracki,

Kłoda,

Jusiak-Kłoda

et al. 2024

IJMS

View full text Add to dashboard Cite

Coronary artery disease (CAD) and hypertension significantly contribute to cardiovascular morbidity and mortality. MicroRNAs (miRNAs) have recently emerged as promising biomarkers and therapeutic targets for these conditions. This systematic review conducts a thorough analysis of the literature, with a specific focus on investigating miRNA expression patterns in patients with CAD and hypertension. This review encompasses an unspecified number of eligible studies that employed a variety of patient demographics and research methodologies, resulting in diverse miRNA expression profiles. This review highlights the complex involvement of miRNAs in CAD and hypertension and the potential for advances in diagnostic and therapeutic strategies. Future research endeavors are imperative to validate these findings and elucidate the precise roles of miRNAs in disease progression, offering promising avenues for innovative diagnostic tools and targeted interventions.

show abstract

Section: Discussionmentioning

confidence: 99%

MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension—A Systematic Review

Kondracki,

Kłoda,

Jusiak-Kłoda

et al. 2024

IJMS

View full text Add to dashboard Cite

show abstract

MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension – a Systematic Review

Kondracki,

Kłoda,

Jusiak-Kłoda

et al. 2024

Preprint

View full text Add to dashboard Cite

Coronary artery disease (CAD) and hypertension significantly contribute to cardiovascular morbidity and mortality. MicroRNAs (miRNAs) have recently emerged as promising biomarkers and therapeutic targets for these conditions. This systematic review conducts a thorough analysis of the literature, with a specific focus on investigating miRNA expression patterns in patients with CAD and hypertension. The review encompasses an unspecified number of eligible studies that employed a variety of patient demographics and research methodologies, resulting in diverse miRNA expression profiles. This review highlights the complex involvement of miRNAs in CAD and hypertension and the potential for advances in diagnostic and therapeutic strategies. Future research endeavours are imperative to validate these findings and elucidate the precise roles of miRNAs in disease progression, offering promising avenues for innovative diagnostic tools and targeted interventions.

show abstract

The Function of Circular RNAs in Myocardial Ischemia–Reperfusion Injury: Underlying Mechanisms and Therapeutic Advancement

Cited by 2 publications

References 119 publications

MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension—A Systematic Review

MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension—A Systematic Review

MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension – a Systematic Review

Contact Info

Product

Resources

About